Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Ursodeoxycholic acid
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ursodeoxycholic acid 250mg capsules
0109010U0AAABAB
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | 45,138 |
|
Ursodeoxycholic acid 500mg tablets
0109010U0AABKBK
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | 17,588 |
|
Ursodeoxycholic acid 150mg tablets
0109010U0AAAAAA
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | 9,444 |
|
Ursodeoxycholic acid 250mg tablets
0109010U0AABLBL
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | 7,772 |
|
Ursodeoxycholic acid 300mg tablets
0109010U0AAAYAY
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | 6,821 |
|
Ursodeoxycholic acid 250mg/5ml oral suspension sugar free
0109010U0AABEBE
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | 4,192 |
|
Ursofalk 250mg capsules
0109010U0BCAAAB
|
Ursofalk | Ursodeoxycholic acid | Gastro-Intestinal System | 1,816 |
|
Cholurso 250mg tablets
0109010U0BFABBL
|
Cholurso | Ursodeoxycholic acid | Gastro-Intestinal System | 1,094 |
|
Ursofalk 500mg tablets
0109010U0BCACBK
|
Ursofalk | Ursodeoxycholic acid | Gastro-Intestinal System | 1,035 |
|
Cholurso 500mg tablets
0109010U0BFAABK
|
Cholurso | Ursodeoxycholic acid | Gastro-Intestinal System | 330 |
|
Ursofalk 250mg/5ml oral suspension
0109010U0BCABBE
|
Ursofalk | Ursodeoxycholic acid | Gastro-Intestinal System | 225 |
|
Destolit 150mg tablets
0109010U0BBAAAA
|
Destolit | Ursodeoxycholic acid | Gastro-Intestinal System | 80 |
|
Ursonorm 500mg tablets
0109010U0BGABBK
|
Ursonorm | Ursodeoxycholic acid | Gastro-Intestinal System | 29 |
|
Ursonorm 250mg capsules
0109010U0BGAAAB
|
Ursonorm | Ursodeoxycholic acid | Gastro-Intestinal System | 28 |
|
Ursodeoxycholic acid 300mg/5ml oral liquid
0109010U0AABHBH
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | 3 |
|
Deoxxa 250mg/5ml oral suspension
0109010U0BHAABE
|
Deoxxa | Ursodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Urdox 300mg tablets
0109010U0BEAAAY
|
Urdox | Ursodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Ursodeoxycholic acid 100mg/5ml oral liquid
0109010U0AABJBJ
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Ursodeoxycholic acid 120mg/5ml oral liquid
0109010U0AAAWAW
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Ursodeoxycholic acid 125mg/5ml oral liquid
0109010U0AAARAR
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Ursodeoxycholic acid 150mg/5ml oral liquid
0109010U0AAANAN
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Ursodeoxycholic acid 200mg/5ml oral liquid
0109010U0AAAUAU
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Ursodeoxycholic acid 250mg/5ml oral liquid
0109010U0AAAJAJ
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Ursodeoxycholic acid 25mg/5ml oral liquid
0109010U0AAAQAQ
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Ursodeoxycholic acid 34mg/5ml oral liquid
0109010U0AABGBG
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.